These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Gut microbiome profiles and associated metabolic pathways in patients of adult-onset immunodeficiency with anti-interferon-gamma autoantibodies. Hsieh HS; Gong YN; Chi CY; Hsieh SY; Chen WT; Ku CL; Cheng HT; Lin L; Sung CM Sci Rep; 2022 Jun; 12(1):9126. PubMed ID: 35650243 [TBL] [Abstract][Full Text] [Related]
32. Microarray-Based Detection of Antibodies against SARS-CoV-2 Proteins, Common Respiratory Viruses and Type I Interferons. Savvateeva E; Filippova M; Valuev-Elliston V; Nuralieva N; Yukina M; Troshina E; Baklaushev V; Ivanov A; Gryadunov D Viruses; 2021 Dec; 13(12):. PubMed ID: 34960822 [TBL] [Abstract][Full Text] [Related]
33. Autoantibodies against type I interferons in COVID-19 infection: A systematic review and meta-analysis. Wang X; Tang Q; Li H; Jiang H; Xu J; Bergquist R; Qin Z Int J Infect Dis; 2023 May; 130():147-152. PubMed ID: 36907547 [TBL] [Abstract][Full Text] [Related]
34. Late-Onset Disseminated Mycobacterium avium intracellulare Complex Infection (MAC), Cerebral Toxoplasmosis and Salmonella Sepsis in a German Caucasian Patient with Unusual Anti-Interferon-Gamma IgG1 Autoantibodies. Hanitsch LG; Löbel M; Müller-Redetzky H; Schürmann M; Suttorp N; Unterwalder N; Mönnich U; Meisel C; Wittke K; Volk HD; Scheibenbogen C; Kölsch U J Clin Immunol; 2015 May; 35(4):361-5. PubMed ID: 25875701 [TBL] [Abstract][Full Text] [Related]
35. The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies. Manry J; Bastard P; Gervais A; Le Voyer T; Rosain J; Philippot Q; Michailidis E; Hoffmann HH; Eto S; Garcia-Prat M; Bizien L; Parra-Martínez A; Yang R; Haljasmägi L; Migaud M; Särekannu K; Maslovskaja J; de Prost N; Tandjaoui-Lambiotte Y; Luyt CE; Amador-Borrero B; Gaudet A; Poissy J; Morel P; Richard P; Cognasse F; Troya J; Trouillet-Assant S; Belot A; Saker K; Garçon P; Rivière JG; Lagier JC; Gentile S; Rosen LB; Shaw E; Morio T; Tanaka J; Dalmau D; Tharaux PL; Sene D; Stepanian A; Mégarbane B; Triantafyllia V; Fekkar A; Heath JR; Franco JL; Anaya JM; Solé-Violán J; Imberti L; Biondi A; Bonfanti P; Castagnoli R; Delmonte OM; Zhang Y; Snow AL; Holland SM; Biggs CM; Moncada-Vélez M; Arias AA; Lorenzo L; Boucherit S; Anglicheau D; Planas AM; Haerynck F; Duvlis S; Ozcelik T; Keles S; Bousfiha AA; El Bakkouri J; Ramirez-Santana C; Paul S; Pan-Hammarström Q; Hammarström L; Dupont A; Kurolap A; Metz CN; Aiuti A; Casari G; Lampasona V; Ciceri F; Barreiros LA; Dominguez-Garrido E; Vidigal M; Zatz M; van de Beek D; Sahanic S; Tancevski I; Stepanovskyy Y; Boyarchuk O; Nukui Y; Tsumura M; Vidaur L; Tangye SG; Burrel S; Duffy D; Quintana-Murci L; Klocperk A; Kann NY; Shcherbina A; Lau YL; Leung D; Coulongeat M; Marlet J; Koning R; Reyes LF; Chauvineau-Grenier A; Venet F; Monneret G; Nussenzweig MC; Arrestier R; Boudhabhay I; Baris-Feldman H; Hagin D; Wauters J; Meyts I; Dyer AH; Kennelly SP; Bourke NM; Halwani R; Sharif-Askari FS; Dorgham K; Sallette J; Sedkaoui SM; AlKhater S; Rigo-Bonnin R; Morandeira F; Roussel L; Vinh DC; Erikstrup C; Condino-Neto A; Prando C; Bondarenko A; Spaan AN; Gilardin L; Fellay J; Lyonnet S; Bilguvar K; Lifton RP; Mane S; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; Anderson MS; Boisson B; Béziat V; Zhang SY; Andreakos E; Hermine O; Pujol A; Peterson P; Mogensen TH; Rowen L; Mond J; Debette S; de Lamballerie X; Burdet C; Bouadma L; Zins M; Soler-Palacin P; Colobran R; Gorochov G; Solanich X; Susen S; Martinez-Picado J; Raoult D; Vasse M; Gregersen PK; Piemonti L; Rodríguez-Gallego C; Notarangelo LD; Su HC; Kisand K; Okada S; Puel A; Jouanguy E; Rice CM; Tiberghien P; Zhang Q; Casanova JL; Abel L; Cobat A Proc Natl Acad Sci U S A; 2022 May; 119(21):e2200413119. PubMed ID: 35576468 [TBL] [Abstract][Full Text] [Related]
36. Examination of autoantibodies to type I interferon in patients suffering from long COVID. Hansen KS; Jørgensen SE; Skouboe MK; Agergaard J; Schiøttz-Christensen B; Vibholm LK; Tolstrup M; Østergaard L; Leth S; Mogensen TH J Med Virol; 2023 Sep; 95(9):e29089. PubMed ID: 37698062 [TBL] [Abstract][Full Text] [Related]
37. Dot enzyme-linked immunosorbent assay strip as a screening tool for detection of autoantibody to interferon gamma in sera of suspected cases of adult-onset immunodeficiency. Rattanathammethee K; Chawansuntati K; Chaiwarith R; Praparattanapan J; Supparatpinyo K; Wipasa J J Clin Lab Anal; 2018 Sep; 32(7):e22460. PubMed ID: 29682788 [TBL] [Abstract][Full Text] [Related]
38. Clinical findings of Talaromyces marneffei infection among patients with anti-interferon-γ immunodeficiency: a prospective cohort study. Chen ZM; Li ZT; Li SQ; Guan WJ; Qiu Y; Lei ZY; Zhan YQ; Zhou H; Lin S; Wang X; Li Z; Yang F; Zeng W; Lin Y; Liu J; Zhang JQ; Ye F BMC Infect Dis; 2021 Jun; 21(1):587. PubMed ID: 34144700 [TBL] [Abstract][Full Text] [Related]
39. Anticytokine autoantibody-associated immunodeficiency. Browne SK Annu Rev Immunol; 2014; 32():635-57. PubMed ID: 24499273 [TBL] [Abstract][Full Text] [Related]
40. [Adult-onset immunodeficiency mediated by anti-IFN-γ autoantibody combined with disseminated mycobacterium marseillense infection: a case report]. Liu JJ; Qin L; Cong Y; Liu HT; Fan JP; Fan HW; Zhou BT; Cao W Zhonghua Nei Ke Za Zhi; 2024 Aug; 63(8):795-799. PubMed ID: 39069870 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]